SD

Surta Devi

Active Director Director DIN 08667959
DIN 08667959 First appointment Jan 2020 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Surta Devi

Data last updated:

Surta Devi is a Director at Veecap Pharmaceuticals Private Limited (since 2020). The company operates in Food And Beverages. Veecap Pharmaceuticals Private Limited reported revenue of ₹13.3 Lakh (FY 2025).

DIN 08667959
Primary Designation Director
Industry Food And Beverages
First Appointment 14 Jan 2020
Oldest Company Age 6 yrs
Largest company Veecap Pharmaceuticals Private Limited · ₹13.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20202020₹13.3 Lakh (FY 2025)Active

Board colleagues of Surta Devi

NameDINCompanyDesignation
Bindu08667958Veecap Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Veecap Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Surta Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surta Devi

Surta Devi currently holds 1 directorship: Veecap Pharmaceuticals Private Limited (Director, since 14 Jan 2020, revenue ₹13.3 Lakh (FY 2025)).

Surta Devi was first appointed on 14 Jan 2020 as Director at Veecap Pharmaceuticals Private Limited.

The current boards of Surta Devi's companies include Bindu (Veecap Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available